A- A A+

Conclusions of the WHO international meeting on prisons and health, Lisbon 2017

Drugs and drug-related harms continue to challenge prison systems in Europe and interventions in this setting must be driven by evidence gathered through monitoring, data-collection and research. The remarks come in conclusions published by the World Health Organization Regional Office for Europe (WHO–Europe), in collaboration with Public Health England and the EMCDDA. (EMCDDA, Lissabon, 13.04.2018)


Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

Cunningham, Evan B. et al.

International Journal of Drug Policy , Volume 54 , 18 - 25


Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

Traci C. Green, Jennifer Clarke, Lauren Brinkley-Rubinstein, Brandon D. L. Marshall, Nicole Alexander-Scott, Rebecca Boss, Josiah D. Rich.

JAMA Psychiatry, 2018; DOI: 10.1001/jamapsychiatry.2017.4614

Research letter, first page


Methadone Versus Torture: The Perspective of the European Court of Human Rights

Junod V., Wolff H., Scholten W., Novet B., Greifinger R., Dickson C., and Simon O.

Heroin Addiction and Related Clinical Problems 20(1):31-36 · February 2018


Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in Rhode Island

A new study in JAMA Psychiatry suggests that treating people for opioid addiction in jails and prisons is a promising strategy to address high rates of overdose and opioid use disorder. (Brown University, Providence Rhode Island, USA, 14.02.2018


Systematic review of qualitative evaluations of reentry programs addressing problematic drug use and mental health disorders amongst people transitioning from prison to communities

Sacha Kendall, Sarah Redshaw, Stephen Ward, Sarah Wayland and Elizabeth Sullivan

Health & Justice2018, 6:4, doi.org/10.1186/s40352-018-0063-8


Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.

Moore KE, Oberleitner L, Smith KMZ, Maurer K, McKee SA.

J Addict Med. 2018 Jan 16. doi: 10.1097/ADM.0000000000000381



Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey.

Kouyoumdjian FG, Patel A, To MJ, Kiefer L, Regenstreif L (2018)

PLoS ONE 13(2): e0192431. https://doi.org/10.1371/journal.pone.0192431


Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision.

Mbaba M, Brown SE, Wooditch A, Kiss M, Murphy A, Kumari S, Taxman F, Altice F, Lawson WB, Springer SA.

Subst Use Misuse. 2018 Jan 15:1-10. doi: 10.1080/10826084.2017.1416400.



Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review.

Kinner SA, Snow K, Wirtz AL, Altice FL, Beyrer C, Dolan K.

J Adolesc Health. 2018 Mar;62(3S):S18-S26. doi: 10.1016/j.jadohealth.2017.09.030.


Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.

Mukherjee TI, Wickersham JA, Desai MM, Pillai V, Kamarulzaman A, Altice FL.

Drug Alcohol Depend. 2016 Jul 1;164:120-7. doi: 10.1016/j.drugalcdep.2016.04.037.


Substitutionsbehandlung im Strafvollzug - Ein praktischer Leitfaden

Jörg Pont, Andrej Kastelic, Heino Stöver, Catherine Ritter, Bärbel Knorr

DAH – Deutsche AIDS-Hilfe, 2018


Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions.

Sharma A, O'Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP.

Subst Abuse Rehabil. 2016 Apr 27;7:27-40. doi: 10.2147/SAR.S81602.


A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.

Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J.

Drug Alcohol Depend. 2018 Mar 1;184:57-63. doi: 10.1016/j.drugalcdep.2017.11.023.



Effectiveness of Treatment Alternatives to Incarceration for Drug-Involved Persons

Roger H. Peters, Lisbon Addictions 2017, Second European Conference on Addictive Behaviours and Dependencies, Lissabon, 24.-26.10.2017

http://www.emcdda.europa.eu/system/files/attachments/7332/11H00_5_Roger Peters.ppt

Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy.

Wakeman SE.

AMA J Ethics. 2017 Sep 1;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709.


The Relationship between Personality Disorders and the Type of Crime Committed and Substance Used among Prisoners.

Fakhrzadegan S, Gholami-Doon H, Shamloo B, Shokouhi-Moqhaddam S.

Addict Health. 2017 Apr;9(2):64-71.

Conclusion: The presence of personality disorders in the target population is indicative of the need for judicial officials’ attention to this effective factor in crime and the use of mental health services and treatment instead of the penalty of deprivation of liberty.


Substitution in Haft - Deine Rechte, Deine Möglichkeiten

In vielen Justizvollzugsanstalten wird nicht bzw. wird nicht ausreichend substituiert. Die Broschüre bietet Informationen für Substituierte, die von Inhaftierung bedroht sind und zeigt Gefangenen, die sich vergeblich um eine Substitution bemühen, welche rechtlichen Schritte möglich sind. (DAH, 2018)


Self-harm in the criminal justice system: a public health opportunity

Borschmann, Rohan et al.

The Lancet Public Health , Volume 3 , Issue 1 , e10 - e11


USA. Moving Ahead on Methadone in Corrections

People who get incarcerated—in prisons or jails—tend to be people with more advanced addiction. If they have opioid use disorders, they typically spend their term without any opioids. When they are released, their tolerance has decreased, and if they relapse—which is likely—they may overdose. That danger was never as great as it is now, explained Josiah D. Rich, MD, MPH, professor of Medicine and Epidemiology at The Warren Alpert Medical School of Brown University, and director of the Center for Prisoner Health and Human Rights at The Miriam Hospital in Providence, Rhode Island.

“The stakes have gotten a lot higher,” Dr. Rich told AT Forum. “We send them back out into the community when the illicit opioid supply has never been so lethal.”

Rhode Island, under the leadership of Gov. Gina Raimondo, has led the state’s initiative to expand opioid treatment with medications to the prison and jail system. She put over $1 million a year into her budget that the General Assembly approved to screen incarcerated people for opioid use disorder and offer them medications for addiction treatment (MAT). Dr. Rich, who treats incarcerated patients, works as a consultant to the Department of Corrections, alongside CODAC Behavioral Healthcare, a not-for-profit opioid treatment program (OTP) that delivers methadone and buprenorphine to inmates. (ATForum, 12.02.2018)


UNODC: thirty years after the global AIDS pandemic started, people who use drugs and prisoners still unduly affected

World AIDS Day has been organized on 1 December every year since 1988. This year's theme "My health, my right" underscores the need for all those affected by HIV to have access to prevention tools and treatment for this deadly disease.

The 2017 campaign stresses everyone's right to make decisions about their health, and to be treated without discrimination and with respect and dignity. These principles are fully supported by UNODC in its own work on HIV inside prisons and with people who use drugs.

To raise awareness of the World AIDS Day, and highlight UNODC's own role, Monica Beg, a doctor and UNODC's Chief of the HIV/AIDS Section, talked about her invaluable work. (UNODC, 01.12.2017)


USA. Methadone improves inmate outcomes

Jail inmates who continue to receive methadone treatment for opioid use disorder have better outcomes both during and after incarceration, according to a new Yale study conducted in conjunction with several state agencies. (Yale News, 02.02.2018)